Back

Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States

Lacek, K. A.; Rambo-Martin, B.; Batra, D.; Zheng, X.-y.; Keller, M. W.; Wilson, M.; Sheth, M.; Davis, M.; Burroughs, M.; Gerhart, J.; Hassell, N.; Lee, J.; Shepard, S. S.; Cook, P. W.; Wentworth, D. E.; Barnes, J. R.; Kondor, R.; Paden, C. R.; Peacock, T. P. R.; Sakaguchi, H.

2022-03-21 genomics
10.1101/2022.03.19.484981 bioRxiv
Show abstract

Recombination between SARS-CoV-2 virus variants can result in different viral properties (e.g., infectiousness or pathogenicity). In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. These genomes are the first evidence for a Delta-Omicron hybrid Spike protein in the United States.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.